Skip to content
Viking Therapeutics Inc icon

Viking Therapeutics Inc

VKTXStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$24.77

Today

-4.1%

YTD

-29.5%

About

Viking Therapeutics Inc is a US-based clinical-stage biopharmaceutical company focused on developing innovative therapies for metabolic and endocrine disorders. Its primary objective is to advance drug candidates that address significant unmet medical needs, improving treatment options for patients worldwide. Operating in the healthcare sector, Viking Therapeutics Inc specialises in small molecule therapeutics. Its development pipeline includes investigational treatments targeting conditions such as obesity, non-alcoholic steatohepatitis (NASH), and rare metabolic diseases. The company aims to deliver impactful therapies that promote long-term health benefits. Explore VKTX share prices and other stocks on eToro. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for VKTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-4.58
P/S (TTM)0.00
P/B (TTM)5.37
Market cap$3.16B
Cap tierMid-cap
Industry avg P/E-17.91

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-96.37%
ROA-73.07%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$5.41
Free cash flow$-462.63M
Total debt$254.69M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.65
Employees53
Next earnings10 Feb '27
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Viking Therapeutics Inc (VKTX) | Dirk Kuyken